Achilles Therapeutics PLC (ACHL) is near the top in its industry group according to InvestorsObserver. ACHL gets an overall rating of 87. That means it scores higher than 87 percent of stocks. Achilles Therapeutics PLC gets a 97 rank in the Biotechnology industry. Biotechnology is number 17 out of 148 industries.
ACHL has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on ACHL!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Achilles Therapeutics PLC Stock Today?
Achilles Therapeutics PLC (ACHL) stock is higher by 0.74% while the S&P 500 has fallen -0.01% as of 11:59 AM on Monday, Feb 26. ACHL has risen $0.01 from the previous closing price of $1.36 on volume of 606,365 shares. Over the past year the S&P 500 has gained 27.78% while ACHL has risen 23.42%. ACHL lost -$1.89 per share the over the last 12 months.
Click Here to get the full Stock Report for Achilles Therapeutics PLC stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
